huHSC-B-NDG hTHPO mice

NOD.CB17-PrkdcscidIl2rgtm1BcgenThpotm1(THPO)Bcgen/Bcgen • 112480

huHSC-B-NDG HLA-A2.1 mice
huHSC-B-NDG MGMT3 mice

huHSC-B-NDG hTHPO mice

Product namehuHSC-B-NDG hTHPO mice
Catalog number112480
Strain nameNOD.CB17-PrkdcscidIl2rgtm1BcgenThpotm1(THPO)Bcgen/Bcgen
Strain backgroundB-NDG
AliasesMGDF, MKCSF, ML, MPLLG, THCYT1, TPO
ApplicationIrradiation is not required to avoid damage to mice caused by irradiation

on this page

  • Efficacy
B-NDG hTHPO mice are well suited for human immune system engraftment

Human CD34+ HSCs (5E5) were intravenously engrafted into wild-type B-NDG mice and homozygous B-NDG hTHPO mice (female, 6-week-old, n=20). B-NDG mice were treated with 2.0 Gy-irradiation. B-NDG hTHPO mice were not irradiated. Flow cytometric analysis of peripheral blood lymphocyte from the two mice after engraftment with human CD34+ HSCs were shown in the figure above. Results showed that the survival rate of B-NDG hTHPO mice was higher than that of B-NDG mice. The percentages of human CD45+ leukocytes, T cells, B cells, NK cells, myeloid cells, monocytes, macrophages and neutrophils in B-NDG hTHPO mice were similar to those in B-NDG mice, demonstrating that the humanized mouse model engrafted with human CD34+ HSCs was successfully constructed. Values are expressed as mean ± SEM. HSCs: hematopoietic stem cells.